2 Xideas Ag Abcam PLC Transaction History

2 Xideas Ag

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 27, 2023	SELL	$21.54 - $24.41 $31.6 Million - $35.8 Million	-1,468,293 Reduced 79.7%	374,079 $8.47 Million
Q3 2023 Nov 07, 2023	BUY	$21.54 - $24.41 $21 Million - $23.8 Million	974,956 Added 112.4%	1,842,372 $41.7 Million
Q2 2023 Aug 10, 2023	BUY	$12.62 - $24.47 $2.63 Million - $5.1 Million	208,281 Added 31.6%	867,416 $21.2 Million
Q1 2023 May 11, 2023	BUY	$12.98 - $17.1 $802,800 - $1.06 Million	61,849 Added 10.36%	659,135 $8.87 Million
Q4 2022 Feb 14, 2023	BUY	$13.92 - $17.0 $8.31 Million - $10.2 Million	597,286 New	597,286 $9.29 Million
Q1 2022 May 16, 2022	SELL	$15.5 - $23.89 $11 Million - $17 Million	-711,273 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$20.04 - $23.84 $14.3 Million - $17 Million	711,273 New	711,273 $16.7 Million

1.03M

Ticker ABCM
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 229,044,992
Description
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include...

Get notified when there are updates to the investment portfolio of 2 Xideas Ag, based on Form 13F filings with the SEC.

Stay updated on 2 Xideas Ag with notifications on news.